PMID- 20422977 OWN - NLM STAT- MEDLINE DCOM- 20110825 LR - 20100428 IS - 2096-7993 (Print) IS - 2096-7993 (Linking) VI - 24 IP - 4 DP - 2010 Feb TI - [Expression and significance of IGF-IR and PKC in laryngeal squamous cell carcinoma]. PG - 152-5 AB - OBJECTIVE: To investigate the expression of IGF-IR and PKC and their clinical significance in laryngeal squamous cell carcinoma(LSCC). METHOD: The expression of IGF-IR and PKC protein were detected by immunohistochemistry and Western blot in 60 cases of LSCC, 25 cases of adjacent non-tumorous laryngeal epithelium and 10 cases of normal laryngeal epithelium. RESULT: The positive rate of IGF-IR and PKC expression in LSCC were significantly higher than that in normal laryngeal epithelium and adjacent non-tumorous laryngeal epithelium (P < 0.05). IGF-IR positive expression were increased more in cases with stage III-IV, cervical lymph node metastasis and well differentiation than that in cases with stage I-II, non-lymph node metastasis and poor/mediate differentiation, respectively (P < 0.05). The positive rate of PKC in LSCC were correlated with clinical stage and cervical lymph node metastasis. There was a correlation between the expression of IGF-IR and PKC in LSCC. CONCLUSION: The overexpression of IGF-IR and PKC in the laryngeal carcinoma may play an important role in the carcinogenesis and development of LSCC. It is suggested that detecting the expression of IGF-IR and PKC can be used for early diagnosis and treatment of LSCC. FAU - Liu, Jie AU - Liu J AD - Department of Otolaryngology-Head and Neck Surgery,Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. FAU - Pan, Song AU - Pan S FAU - Zhou, Yuanhong AU - Zhou Y FAU - Yu, Zhihua AU - Yu Z FAU - Liu, Lisi AU - Liu L LA - chi PT - English Abstract PT - Journal Article PL - China TA - Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi JT - Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery JID - 101303164 RN - EC 2.7.10.1 (Receptor, IGF Type 1) RN - EC 2.7.11.13 (Protein Kinase C) SB - IM MH - Adult MH - Aged MH - Carcinoma, Squamous Cell/*metabolism/pathology MH - Female MH - Humans MH - Laryngeal Neoplasms/*metabolism/pathology MH - Male MH - Middle Aged MH - Protein Kinase C/*metabolism MH - Receptor, IGF Type 1/*metabolism EDAT- 2010/04/29 06:00 MHDA- 2011/08/27 06:00 CRDT- 2010/04/29 06:00 PHST- 2010/04/29 06:00 [entrez] PHST- 2010/04/29 06:00 [pubmed] PHST- 2011/08/27 06:00 [medline] PST - ppublish SO - Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2010 Feb;24(4):152-5.